Somavaratan

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameSomavaratan
Drug Alias Name伐拉生长素Somavaratan (Versartis)伐雷生长素Recombinant human growth hormone long-acting (Versartis)Somatropin long-acting (Versartis) +[11] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiencyGrowth Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaGermany +[5] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVersartis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVersartis Inc
Active IndicationsN/A
Inactive IndicationsGrowth hormone deficiencyGrowth Disorders

Other Information

ATC CodeN/A
Related LinksN/A